DOCSLIB.ORG

Fast 500 2017 NORTH AMERICA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Fast 500 2017 NORTH AMERICA 500TM Technology Fast 500 2017 NORTH AMERICA 2017 Technology Fast 500 Recognizing growth The fastest growing technology companies START Updated November 9, 2017 at 7 p.m. EST ABOUT DELOITTE’S TECHNOLOGY FAST 500 THE TOP TEN BY THE NUMBERS THE LIST BIOTECHNOLOGY/PHARMACEUTICAL COMMUNICATIONS/NETWORKING Contents DIGITAL CONTENT/MEDIA/ENTERTAINMENT ELECTRONIC DEVICES/HARDWARE ENERGY TECH MEDICAL DEVICES SEMICONDUCTOR SOFTWARE CONTACTS As used in this document, “Deloitte” means Deloitte & Touche LLP, Deloitte Tax LLP, Deloitte Consulting LLP, Deloitte Financial Advisory Services LLP, and Deloitte Transactions and Business Analytics LLP which are MORE INFORMATION separate subsidiaries of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. 2 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 About Deloitte’s Technology Fast 500 The Deloitte Technology Fast 500 is the leading technology awards program in North America (US and Canada) with 2017 being its twenty-third anniversary. Combining technological innovation, entrepreneurship, and rapid growth, Fast 500 companies—large, small, public, and private—span a variety of industry sectors, and are leaders in hardware, software, telecom, semiconductors, life sciences, and emerging areas, such as clean technology. These companies are on the cutting edge and are transforming the way we do business today. SELECTION AND QUALIFYING CRITERIA Technology Fast 500 provides a ranking of the fastest growing technology, media, telecommunications, life sciences, and energy tech companies—both public and private—in North America. Technology Fast 500 award winners for 2017 are selected based on percentage fiscal year revenue growth during the period from 2013 to 2016. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD, and current-year operating revenues of at least $5 million USD. Additionally, companies must be in business for a minimum of four years, and be headquartered within North America. This ranking is compiled from nominations submitted directly to the Technology Fast 500 website, and public company database research conducted by Deloitte LLP. PROGRAM INFORMATION If you would like to learn more about the Technology Fast 500 program, please register here to receive e-mail alerts. To download a copy of 2017 rankings go to: www.Fast500.com. 3 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 The Top Ten Rank Company name Primary industry % Growth City St./Prov. CEO name 1 Donuts Inc. Communications/networking 59,093% Kirkland WA Bruce Jaffe 2 ClassPass Inc. Software 46,556% New York NY Fritz Lanman 3 Toast Software 31,250% Boston MA Chris Comparato 4 Aratana Therapeutics, Inc. Biotechnology/pharmaceutical 31,242% Leawood KS Steven St. Peter 5 Theravance Biopharma US, Inc. Biotechnology/pharmaceutical 21,426% South San Francisco CA Rick E Winningham 6 Liftoff Software 16,981% Palo Alto CA Mark Ellis 7 SalesLoft Software 13,759% Atlanta GA Kyle Porter 8 ShipHawk Software 13,638% Santa Barbara CA Jeremy Bodenhamer 9 iSpot.tv Software 13,323% Bellevue WA Sean Muller 10 Cylance Inc. Software 13,057% Irvine CA Stuart McClure 4 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 By the numbers 17 of the top 20 are private 70% companies companies 3-year 120 have received growth rate: 66% 34% companies had venture Private Public capital/private 1,000% growth equity funding 59,093% or higher in their history 135% Software remains the leading industry with 293 companies. Biotechnology/pharmaceutical is on the rise with a 4% increase from last year. 5 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 By the numbers (cont.) Artificial 11% 1% intelligence DIGITAL CONTENT/MEDIA/ Cloud ENTERTAINMENT 7% services 9% Data 17% analytics BIOTECHNOLOGY/ PHARMACEUTICAL Consumer 4% software Enterprise 4% 19% software MEDICAL DEVICES WINNERS BY INDUSTRY SECTOR 59% 4% SOFTWARE COMMUNICATIONS/ NETWORKING 6% Mobile 3% 43% SaaS ELECTRONIC 1% DEVICES/HARDWARE ENERGY TECH 9% Security Internet 1% Social 1% of things 1% networking SEMICONDUCTOR 6 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 By the numbers (cont.) 3-YEAR MEDIAN PERCENTAGE GROWTH RATE—BY SECTOR 170% 219% 226% 232% 244% 371% 453% 543% Semiconductor Medical devices Energy tech Communications/ Electronic Software Biotechnology/ Digital content/ networking devices/hardware pharmaceutical media/ entertainment 7 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 By the numbers (cont.) 2017 TECHNOLOGY FAST 500 COMPANIES BY COMPANY HEADQUARTERS 70 CANADA 25 Seattle 2 2 Minnesota 1 Portland 1 1 Wisconsin Idaho Michigan 32 1 12 12 7 79 New England 5 Iowa Chicago 1 2 Salt Lake 1 Ohio 12 Tri-State City Pittsburgh 27 91 Denver 2 Philadelphia Nevada Indiana 1 Greater Washington Silicon Valley/ Missouri 1 Kentucky SF Bay Area 38 2 Oklahoma 6 LA/Orange New 19 County 16 Mexico Arizona 8 Carolinas Dallas 1 Atlanta San Diego 4 4 Alabama Central Texas/ Austin Houston 14 Florida 8 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 The list The following listing has been sorted by industry and rank. To view the list by overall ranking, visit www.Fast500.com. Ranking determined based on a tenth of a percentile. BIOTECHNOLOGY/PHARMACEUTICAL RANK COMPANY NAME % GROWTH CITY ST./PROV. CEO NAME 4 Aratana Therapeutics, Inc. 31,242% Leawood KS Steven St. Peter 5 Theravance Biopharma US, Inc. 21,426% South San Francisco CA Rick E. Winningham 26 Coherus BioSciences, Inc. 6,810% Redwood City CA Dennis Lanfear 36 AGTC 4,928% Alachua FL Sue Washer 46 Lexicon Pharmaceuticals, Inc. 3,651% The Woodlands TX Lonnel Coats 49 Acura Pharmaceuticals, Inc. 3,529% Palatine IL Robert B. Jones 54 NewLink Genetics Corporation 3,172% Ames IA Charles J. Link Jr., M.D. 55 Innoviva, Inc. 2,847% Brisbane CA Michael W. Aguiar 60 Trevena, Inc. 2,678% Chesterbrook PA Maxine Gowen 68 Exact Sciences Corporation 2,324% Madison WI Kevin Conroy 73 Eleven Biotherapeutics 2,147% Cambridge MA Stephen A. Hurly 79 Navidea Biopharmaceuticals, Inc. 1,843% Dublin OH Michael M. Goldberg, M.D. 84 Alimera Sciences, Inc. 1,707% Alpharetta GA Dan Myers 85 Supernus Pharmaceuticals, Inc. 1,689% Rockville MD Jack A. Khattar 9 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 The list (cont.) BIOTECHNOLOGY/PHARMACEUTICAL RANK COMPANY NAME % GROWTH CITY ST./PROV. CEO NAME 86 Sorrento Therapeutics, Inc. 1,672% San Diego CA Henry Ji 90 CytomX Therapeutics, Inc. 1,594% South San Francisco CA Sean McCarthy 96 Intercept Pharmaceuticals, Inc. 1,438% New York NY Mark Pruzanski 97 T2 Biosystems, Inc. 1,434% Lexington MA John McDonough 98 Acadia Pharmaceuticals, Inc. 1,414% San Diego CA Stephen R. Davis 106 Eagle Pharmaceuticals Inc. 1,283% Woodcliff Lake NJ Scott Tarriff 107 Adaptive Biotechnologies 1,274% Seattle WA Chad Robins 109 Amicus Therapeutics, Inc. 1,266% Cranbury NJ John F. Crowley 116 Opko Health, Inc. 1,166% Miami FL Phillip Frost 117 Ironwood Pharmaceuticals 1,097% Cambridge MA Peter Hecht 127 Alliqua BioMedical, Inc. 913% Yardley PA David Johnson 130 Orexigen Therapeutics, Inc. 883% La Jolla CA Michael Narachi 140 Progenics Pharmaceuticals, Inc. 783% New York NY Mark Baker 141 Neos Therapeutics, Inc. 776% Grand Prairie TX Vipin Garg 145 Xencor, Inc. 761% Monrovia CA Bassil I. Dahiyat, Ph.D. 146 ZIOPHARM Oncology, Inc. 758% Boston MA Laurence J.N. Cooper 10 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 The list (cont.) BIOTECHNOLOGY/PHARMACEUTICAL RANK COMPANY NAME % GROWTH CITY ST./PROV. CEO NAME 150 Immune Design 729% Seattle WA Carlos Paya, M.D., Ph.D. 153 Intrexon 704% Blacksburg VA Randal J. Kirk 158 Corcept Therapeutics, Inc. 685% Menlo Park CA Joseph K. Belanoff 167 Agenus Inc. 641% Lexington MA Garo Armen 168 Proteostasis Therapeutics, Inc. 635% Cambridge MA Meenu Chhabra 174 Ocera Therapeutics, Inc. 616% San Diego CA Linda Grais 176 Athersys, Inc. 612% Cleveland OH Gill Van Bokkelen 180 Fate Therapeutics, Inc. 603% San Diego CA Scott Wolchko 190 AMAG Pharmaceuticals, Inc. 558% Waltham MA William K. Heiden 203 Exelixis, Inc. 511% San Francisco CA Michael M. Morrissey 213 Viveve, Inc. 461% Englewood CO Patricia Scheller 218 Glaukos Corporation 446% San Clemente CA Thomas W. Burns 233 Neurocrine Biosciences, Inc. 414% San Diego CA Kevin C. Gorman 236 Pfenex, Inc. 405% San Diego CA Eef Schimmelpennink 239 CV Sciences, Inc. 403% Las Vegas NV Michael J. Mona 249 Geron Corporation 380% Menlo Park CA John Scarlett 11 2017 Technology Fast 500 | Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 The list (cont.) BIOTECHNOLOGY/PHARMACEUTICAL RANK COMPANY NAME % GROWTH CITY ST./PROV. CEO NAME 256 Keryx Biopharmaceuticals, Inc. 357% Boston MA Greg Madison 275 Vanda Pharmaceuticals, Inc.
Load more

Recommended publications
  • 3588539 Tf500 2016
    2016 Technology Fast 500 Recognizing growth START The fastest growing technology companies Contents ABOUT DELOITTE’S TECHNOLOGY FAST 500 THE TOP TEN BY THE NUMBERS THE LIST BIOTECHNOLOGY/PHARMACEUTICAL COMMUNICATIONS/NETWORKING DIGITAL CONTENT/MEDIA/ENTERTAINMENT ELECTRONIC DEVICES/HARDWARE ENERGY TECH MEDICAL DEVICES SEMICONDUCTORS SOFTWARE CONTACTS As used in this document, “Deloitte” means Deloitte LLP and its subsidiaries. Please see www.deloitte.com/us/about MORE INFORMATION for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting. 2 2016 Technology Fast 500 Recognizing growth ABOUT DELOITTE’S BY THE MORE THE TOP TEN THE LIST CONTACTS TECHNOLOGY NUMBERS INFORMATION FAST 500 About Deloitte’s Technology Fast 500 The Deloitte Technology Fast 500 is the leading technology awards program in North America (US and Canada) with 2016 being its twenty-second anniversary. Combining technological innovation, entrepreneurship, and rapid growth, Fast 500 companies—large, small, public, and private—span a variety of industry sectors, and are leaders in hardware, software, telecom, semiconductors, life sciences, and emerging areas, such as clean technology. These companies are on the cutting edge and are transforming the way we do business today. Selection and qualifying criteria Technology Fast 500 provides a ranking of the fastest growing technology, life sciences, and energy tech companies—both public and private—in North America. Technology Fast 500 award winners for 2016 are selected based on percentage fiscal year revenue growth during the period from 2012 to 2015. In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues.
    [Show full text]
  • Melanoma Research Alliance Progress Report 2013–2014 Contents
    Melanoma Research Alliance Progress Report 2013–2014 Contents About Us 4 Science 7 Policy 16 Partnerships & Support 18 Events 21 Outreach & Communications 24 Supporters & Financials 28 1 Letter From the Chair & President This year has seen game-changing progress on treatment of melanoma, including the first anti- behalf of melanoma patients. New treatments are PD-1 drugs, dramatically improving the outlook for saving lives and providing real hope that we are patients. Melanoma research has energized the closer than ever to our goal of eliminating suffering entire field of oncology and charted a new course and death from melanoma. in cancer treatment for a variety of tumor types. At the Melanoma Research Alliance (MRA), we This report summarizes our many exciting are committed to funding cutting-edge research accomplishments over the past 12 months and to speed the delivery of cures for all melanoma puts in perspective our strategy to capitalize on patients and everyone at risk for this deadly the progress made. We know that our work is not disease. yet finished, as existing treatments still benefit too few melanoma patients, and there is much left to In 2014, MRA awarded a historic $11 million do in identifying better ways to prevent, detect and in research funding to 34 investigators at 19 treat this disease. Through partnerships with all academic institutions, increasing MRA’s cumulative stakeholders and a firm commitment to fund the total funding since we began in 2007 to more than most impactful scientific research, we are building $60 million. MRA’s investment has catalyzed an on the momentum in the field and leading the additional $66 million in leveraged funding from way toward revolutionary approaches in cancer other sources, which brings the total applied to treatment.
    [Show full text]
  • Crain's New York Business
    CRAINSNEW YORK BUSINESS Oscar turns grouchy on New York P. 7 | VCs sink their teeth into food P. 8 | What singles signify for lower Manhattan P. 13 NEW YORK BUSINESS® OCTOBER 10 - 16, 2016 | PRICE $3.00 How CEO John Foley steered exercise-bike company Peloton to a seven-figure growth rate and $43 million in revenue. PLUS: The 49 other hottest companies in New York Page 17 VOL. XXXII, NO. 41 WWW.CRAINSNEWYORK.COM NEWSPAPER P001_CN_20161010.indd 1 10/7/16 8:13 PM WE HEAR YOU, MARIO. With Express Funding, get your card payments in your Chase checking account the next business day. Chase.com/ExpressFunding All businesses are subject to credit approval. Next business day funding is available to eligible Chase merchant services clients who deposit into a single Chase business checking account. Visa®, MasterCard® and Discover® credit and debit transactions are eligible. Additional terms, conditions and restrictions apply. Merchant services are provided by Paymentech, LLC (“Chase”), a subsidiary of JPMorgan Chase Bank, N.A. Real business owners compensated for use of their actual statements. Deposit products offered by JPMorgan Chase Bank, N.A. Member FDIC ©2016 JPMorgan Chase & Co. Untitled-11 1 8/30/2016 12:13:11 PM OCTOBER 10 - 16, 2016 CRAINSNEW YORK BUSINESS FROM THE NEWSROOM | JEREMY SMERD IN THIS ISSUE Call the commissioner 4 AGENDA WITH ALL THE NEW MANDATES New York City businesses must 6 IN CASE YOU MISSED IT Central Park comply with, it’s no wonder Mayor Bill de Blasio has had to 7 HEALTH CARE Conservancy CEO on rich expand government to police them.
    [Show full text]
  • AGENDA 24 Seven Renée Hill, Co-CEO & President November 5, 2014 Eyereturn Marketing New York Meredith Flynn-Ripley, CEO Heywire Business
    6:45-7:30 Reception 7:30 Dinner 7:45 Speaker Introductions Celeste Gudas, CEO AGENDA 24 Seven Renée Hill, Co-CEO & President November 5, 2014 eyereturn marketing New York Meredith Flynn-Ripley, CEO HeyWire Business Will Margiloff, CEO IgnitionOne Harry Kargman, CEO Kargo Todd Rose, SVP NinthDecimal Doug Shattuck, CFO OwnerIQ Matt Moog, CEO PowerReviews Jonathan Ewert, CEO Reputation Institute Brendan Condon, CEO REVShare Zac Moffatt, Co-Founder Targeted Victory Finn Faldi, CEO & President Trueffect John Zubak, CEO VIIAD Systems Dana Arnett, CEO Please contact us if you would like to VSA Partners arrange a meeting or call with one of these presenters outside of this event. Ash Kalb, Co-Founder White Ops 9:00-9:30 Cocktails & Networking Celeste Gudas Renée Hill CEO Co-CEO & President 24 Seven eyereturn marketing Celeste is a distinguished Over the course of 20 entrepreneur and recruit- years in the media industry, ing industry innovator, Renée has never stopped who launched 24 Seven innovating. Building on in 2000 as a talent progressively senior roles in solutions partner for media buying, research, and fashion, luxury, beauty, and retail companies. One of sales, by the year 2000, the fastest growing, privately held staffing firms, the Renée was ready for the company has expanded from a single New York office challenge of starting a to 13 locations, including Toronto, Paris, and London. digital technology company. Since then, eyereturn Today, 24 Seven is the leading specialized talent search marketing has grown within a hyper-competitive firm for global brands and emerging companies industry to become a company of more than 80 worldwide in fashion, retail, advertising, marketing, people with four offices in the U.S.
    [Show full text]
  • A Glimpse of Tomorrow No Limits for Today’S Visionary Award Winners
    SPECIAL EDITION VOLUME 1 WWW.REDHERRING.COM Featuring: Red Herring TOP 100 COMPANIES $3.99 / $4.99 CANADA RED RED HE rr ING MAGAZINE ING MAGAZINE | SPECIAL E DITION 2014 VOLU 2014 DITION M E 1 E A GLIMPSE OF TOMORROW No limits for Today’s Visionary Award Winners TOP Top Technology Companies Technology Europe & North America Companies Alert, Interact & Account for Your People in Times of Crisis MANAGE ACCOUNT REPORT NOTIFY Your Turn? BIMOBJECT® IS A GAME CHANGER FOR THE CONSTRUCTION INDUSTRY WORLDWIDE WITH ITS CLOUD BASED PORTAL OFFERING DEVELOPMENT, MAINTENANCE AND SYNDICATION OF DIGITAL REPLICAS – BIM OBJECTS – OF MANUFACTURED BUILDING AND INTERIOR PRODUCTS. THE MARKETING AND PRE-SALES SERVICES ASSOCIATED AtHoc Revolutionizes Enterprise Life Safety & Security WITH THE PORTAL ARE CHANNELLED AND INTEGRATED, Leveraging the latest advances in mobile, cloud, and IP technologies to deliver THROUGH SPECIALISED SOFTWARE, INTO CAD/BIM APPLICATIONS TO CREATE A BUSINESS-TO-BUSINESS state-of-the-art interactive crisis communication. COMMUNICATION ACROSS THE GLOBE. • Mission-proven and deployed for over 75% of U.S. military & homeland security • Leading enterprise customers include: Microsoft, Kaiser Permanente, Texas A&M MANUFACTURERS USE BIMOBJECT® TO PROMOTE AND DELIVER THEIR PRODUCTS DIRECTLY INTO BIM PROCESSES • Fastest growing mass notification software supplier in N.A., doubling its market share* ENABLING THEIR PRODUCTS TO BE SELECTED AND GENERATE • Backed by Greylock and Intel Capital A REAL IMPROVEMENT IN SALES. TO FIND OUT MORE VISIT THE BIMOBJECT® WEBSITE: BIMOBJECT.COM Apply the power of AtHoc to your enterprise. Call 650-685-3000 or visit www.athoc.com * IHS 2013 Market Research BIMOBJECT CORPORATE HEADQUARTERS: MEDIA EVOLUTION CITY, STORA VARVSGATAN 6 A 211 19 MALMÖ, SWEDEN BIMOBJECT.COM | PHONE: +46 40 685 29 00 Network-Centric Interactive Crisis Communication Red Herring Magazine Red Herring Magazine 10 118 top 100 award In this issue, the Red Herring Top 100 award highlights the most exciting startups from Europe and the Americas.
    [Show full text]
  • Snapshot of Progress 2012-2013
    SNAPSHOT OF PROGRESS 2012-2013 1101 New York Avenue NW, #620 Washington, cDC,urem 20009elanoma.org It’s been a year of exciting collaborations that connect multiple research programs with critical investments. The Melanoma Research Alliance (MRA), a unique foundation launched by Debra and Leon Black under the auspices of the Milken Institute, works to accelerate scientific discovery to eliminate death and suffering due to melanoma. Over the past year, MRA has worked tirelessly to achieve this goal, aided by scientific researchers, funders, corporate and non- profit allies, and volunteers. To date, MRA has awarded more than $49 million in funding to 118 innovative, translational research programs led by 171 Principal Investigators at 80 institutions in 14 countries. In August 2013, MRA released its latest Request for Proposals with plans to award at least $8 million (in the spring of 2014) including its first regional special opportunity. A key component of MRA’s unique research program emphasizes collaboration within and across sectors. The melanoma landscape is evolving quickly, and the foundation has been laid for new, more successful approaches to treat this deadly cancer. As a result, there is unprecedented opportunity for transformational progress on behalf of patients, and all who are at risk, with more than 100 new melanoma compounds in the pipeline and nearly 300 clinical trials underway. MRA also runs multiple awareness campaigns to promote sun safety and encourage early melanoma detection. The work of our allies plays a key role in new prevention and early detection efforts, amplifying our message. With all of these diverse stakeholders committed to fighting melanoma on multiple fronts, we are optimistic that the day when no one will suffer or die from melanoma is within reach.
    [Show full text]
  • Through Afterschool Development
    CREATING COMMUNITIES THROUGH AFTERSCHOOL DEVELOPMENT 2016 ANNUAL REPORT OUR MISSION The All Stars Project transforms the lives of youth and poor communities using the developmental power of performance, in partnership with caring adults. OUR VISION By 2020, the All Stars Project will be recognized as America’s action and thought leader in Afterschool Development, a new way of engaging poverty. OUR VALUES Integrity and trust Partnership with the poor Building community Radically inclusive Imagining possibility Improving the world Dear Friends, At a moment when people across the country and the world are working to overcome deep divisions, I am so proud to be joining with people of all ages and from all walks of life to grow a national development community filled with possibility and hope. The All Stars began working in poor neighborhoods 36 years ago, and we never left — we continue to stand on street corners, knock on doors in housing projects and walk the halls of struggling schools to offer thousands of young people and families an opportunity to be part of creating something new in their lives. Across America, All Stars' mission and vision are being championed and shaped by forward-looking and committed partners who are passionate about opening up pathways of opportunity for inner- city youth. Privately funded from the start, last year the All Stars Project raised over $9.7 million from more than 3,500 donors who are dedicated to partnering with youth and finding new ways to strengthen our American community. With this support, we have launched a campaign to establish our third Center for Afterschool Development — this one in Chicago’s downtown Loop.
    [Show full text]
  • Alumni Career Paths
    ABs to CVs: Government Alumni Career Paths Academia Business Education Government Jack of All Trades Law Media Medicine Military Academia Dara L. Sosulski, ‘03: I had always harbored substantially wide-ranging academic interests, so when I arrived at Harvard, I was unsure about which concentration to choose—I had serious interests in political philosophy, biology, literature, and writing. Ultimately, I decided to pursue a degree in Government, because the concentration gave me the opportunity to study all of the aforementioned—some within the confines of my concentration requirements, and some within the generous time the government concentration allows for elective courses. I am now a Ph.D candidate in the department of Neurobiology and Behavior at Columbia University, doing my thesis research in the laboratory of Nobel Laureate Richard Axel, MD. My studies in government gave me a solid footing in the analytical reading and clear, direct writing skills critical for a successful career in science, and I will always be grateful to the government program for giving me the opportunity to sample many courses from other departments as well. Alex Kuo, ’01: After graduation I worked for one year as a Junior Fellow for the Carnegie Endowment for International Peace in Washington, DC. During my time in DC I decided to apply to doctoral programs in political science. I am currently working towards a PhD at Stanford University, researching and writing my dissertation. I enjoyed being a Government concentrator, and through classes and friendships I became exposed to a wide variety of possible career and job choices. Ragan Buckley, ’00: I am following a career path that’s probably not very typical for a Government graduate – I’m working on my Ph.D.
    [Show full text]
  • November 14, 2017 the Honorable Orrin Hatch Chairman Senate
    November 14, 2017 The Honorable Orrin Hatch Chairman Senate Finance Committee 104 Hart Office Building Washington, DC 20510 Dear Chairman Hatch: We are a group of startups, investors, and innovators deeply concerned about the proposed changes to the taxation of non-qualified deferred compensation plans in Section III(H)(1) of the Tax Cuts and Jobs Act. This shift would have profound negative consequences for technology start-ups by, among other things, undermining their ability to compete with large incumbents for employees. Section III(H)(1) would require both tax assessment and payment on stock options and other stock-based incentive compensation upon vesting instead of exercise, distribution, or any other liquidity event. The current law, embodied in Section 409A of the Tax Code, enshrines the common-sense notion that employees should pay taxes on income that they actually receive. By making the mere vesting of a stock option a taxable event, an employee would have to pay a tax based upon a hypothetical gain that could take years to become liquid and may never materialize into cash. This would transform stock-based incentive programs from benefits to liabilities overnight and would effectively bar startups from offering this form of compensation. We cannot overemphasize how essential stock-based compensation is to a startup’s ability to recruit and retain talent. Startups do not have the ability to compete with larger firms based upon cash compensation. A startup’s ability to issue stock options levels the playing field by giving potential employees something unique: the ability to share in the company’s rewards as well as its risks and participate in the upside of a new and exciting venture.
    [Show full text]
  • Upper East Side
    Coordinates: 40.769°N 73.966°W Upper East Side The Upper East Side is a neighborhood in the borough of Manhattan in New York City, between Central Park/Fifth Avenue, 59th Street, Upper East Side the East River, and 96th Street.[2] The area incorporates several Neighborhood of Manhattan smaller neighborhoods, including Lenox Hill, Carnegie Hill, and Yorkville. Once known as the Silk Stocking District,[3] it is now one of the most affluent neighborhoods in New York City.[4] Contents History Development Famous residents move in Transportation constructed Geography Historic district Park Avenue on the Upper East Side, lined with apartment buildings, looking north fromEast Demographics 74th Street (September 2016) Politics Landmarks and cultural institutions Museums Art galleries Hotels Houses of worship Diplomatic missions Post offices Transportation Education Primary and secondary schools Public schools Location in New York City Private schools Coordinates: 40.769°N 73.966°W Colleges and universities Country United States Public libraries State New York In popular culture County New York Films City New York City Television shows Borough Manhattan Books Area Fictional places and characters • Total 1.76 sq mi (4.6 km2) Notable people • Land 1.76 sq mi (4.6 km2) See also • Water 0 sq mi (0 km2) References Population (2010) External links • Total 229,688 • Density 130,504.5/sq mi (50,388.1/km2) History 2010 figures for Manhattan CB 8[1] Development Ethnicity • White 89.3% [5] Before the arrival of Europeans, the mouths of streams that eroded
    [Show full text]
  • 2016–2017 Annual Report Board of Directors
    RECAP 2016–2017 ANNUAL REPORT BOARD OF DIRECTORS Honorary Chair Co-Chairs Chairman Emeritus Liz Smith Katharine Raymond Hinton Peter Brown LITERACYMike Steib BOARD MEMBERS Alina Cho Mark Gurevich Kate Schroeder O’Neill Courtney Corleto Jesse Haines Liz Perl Tracy Corrigan Lawrence A. Jacobs Sharon Rodriguez PARTNERDaniel Costello John H. Josephson Jeffrey Sharp Matthew Derella Leslie Klotz Samantha Yanks Lee V. Eastman Parker B. Ladd David Eun Todd Larsen STAFF S SungRECAP E Bai Flor de Maria Eilets Lionel OuelletteLI Chief Operating Officer Social Worker Director of Programs Sari Barocas Yevgeniya Gershkovich David Rothenberg English for Parents Teacher Senior Bookkeeper Analytics Manager and Site Coordinator Emily Harting Timothy Ruffin Aissatou Bayo Director of Development HSE Curriculum CUNY Service Corp Fellow and Communications Developer and Lead Teacher TERACYPPhil Cameron Adriane Lee Adult Basic Education and High English for Parents Teacher Allison Sciplin School Equivalency Teacher and Site Coordinator Deputy Director of Development Sandra Cespedes Vulcanus Levi English for Parents Teacher Program Coordinator Hawley Sealey and Site Coordinator Math Instructor Katie Ly Gohar Chichian Special Projects Manager Anthony Tassi Development and Chief Executive Officer ARTNERSCommunications Manager Kate Maloy High School Equivalency Lorna Torres Hilary Downes Teacher Executive Assistant LITERACYEducational Counselor TABLE OF CONTENTS Letter from the CEO ................................................2 Results: Educational Gains ..........................................3
    [Show full text]